紫杉醇(tax、泰素、特素、紫素)(Paclitaxel (Taxol, tax, paclitaxel, paclitaxel)).doc

紫杉醇(tax、泰素、特素、紫素)(Paclitaxel (Taxol, tax, paclitaxel, paclitaxel)).doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
紫杉醇(tax、泰素、特素、紫素)(Paclitaxel (Taxol, tax, paclitaxel, paclitaxel))

紫杉醇(tax、泰素、特素、紫素)(Paclitaxel (Taxol, tax, paclitaxel, paclitaxel)) [name of drug] Paclitaxel English Name: Paclitaxel Other name: Paclitaxel, taxol, paclitaxel, paclitaxel, Anzatax, Paclitaxelum, PTX, Taxol [clinical application] Mainly used for the treatment of ovarian cancer and breast cancer (ovarian cancer after first-line chemotherapy or chemotherapy; multiple failure after combination chemotherapy in metastatic breast cancer failed or breast cancer recurrence within 6 months of adjuvant chemotherapy), and has a certain curative effect on lung cancer, esophageal cancer, gastric cancer, colorectal cancer, soft tissue sarcoma, melanoma, head and neck cancer, lymphoma, brain tumor, seminoma etc.. [pharmacology] 1. pharmacodynamics. This medicine is an anticancer drug extracted from short leaf yew (Taxus brevis) or semisynthetic. Can be applied to the microtubule / microtubule system, promote tubulin assembly into microtubules, but also inhibit the depolymerization of microtubules, which leads to the abnormal arrangement of microtubules, the formation of star shaped body, the spindle lose normal function, leading to cell death. The drug also induces the formation of nonfunctional microtubules in the absence of guanosine three phosphate (GTP) and microtubule associated protein (MAP). In the screening of human tumor cell lines and experimental animals, this medicine is effective for many kinds of tumors and belongs to broad-spectrum antitumor agents. For cisplatin and doxorubicin resistant individuals, the use of this drug is also effective. 2. 、 the peak concentration (Cmax) of serum was 435-802ng/mL after intravenous drip, and the concentration of serum could reach the level of cytotoxic activity 6-12 hours after the end of infusion (85ng/mL). The binding rate of plasma protein was 89%-98%. In the plasma, the elimination was two compartment model, with an average half-life of alpha phase of 0.27 hours, and a beta phase of 6.4 hours. Mainly metabolized in the liver

文档评论(0)

f8r9t5c + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:8000054077000003

1亿VIP精品文档

相关文档